Answers are grounded in this paper and cite their sources.
This study re-examined the Memory Assessment Scale (MAS), a brief memory test developed in Hawai‘i in 1987, to assess whether it remains a valid and reliable cognitive impairment screening tool in Hawai‘i. Patients suspected of having neurocognitive dysfunction were divided into 2 groups (those with and without mild cognitive impairment) based on their results on a battery of neuropsychological tests. No differences in MAS scores were found between patients with and without mild cognitive impairment. Further research with the MAS comparing patients with mild cognitive disorder to healthy controls is indicated to further examine the efficacy of this population-based test.
No takes yet. Share an insight, caveat, or question.
Tsushima et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: